Every SEC Form 3/4/5 on record for this filer (CIK 1731164) — 3 issuers, 35 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS, INC. | Director | 2023-10-02 → 2026-02-11 | 4 | — |
| DBTX | Decibel Therapeutics, Inc. | Director · lapsed | 2021-12-06 → 2023-09-25 | 5 | — |
| BLUE | bluebird bio, Inc. | Chief Commercial Officer · lapsed | 2018-02-20 → 2021-01-08 | 18 | −$439,655 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| BLUE | 2021-01-06 | Sell | 759 | $45.46 | $34,504 | 25,103 |
| BLUE | 2021-01-06 | Sell | 1,055 | $44.76 | $47,222 | 25,862 |
| BLUE | 2021-01-05 | Sell | 40 | $44.95 | $1,798 | 26,917 |
| BLUE | 2020-12-02 | Sell | 35 | $46.19 | $1,617 | 26,958 |
| BLUE | 2020-12-02 | Sell | 1 | $46.50 | $47 | 26,957 |
1 of 3 issuers are covered and open a security page; the rest are on file here only.
